Tuberculosis, vaccine and regulatory experts convened at a scientific symposium to discuss clinical development aspects of TB vaccine research in Bethesda, Maryland, on September 7, 2011. This event marked the second meeting on TB vaccine research of a new bi-annual symposium program co-sponsored by Aeras and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health.

Greater political will needed to address TB vaccine development and future introduction challenges

A scientific symposium to kick-start discussion on novel areas of TB vaccine research was held in Bethesda, Maryland on March 7, 2011.

At a global gathering on TB vaccine development in Tallinn, Estonia (21-24 September 2010), the world’s top TB vaccine scientists, researchers and advocates met to review progress and challenges in the TB vaccine field and to set a renewed course for future directions in the TB vaccine development.

Geneva, Switzerland (May 19, 2010) – An article summarizing the need and the current progress of new vaccines against tuberculosis appeared today in the scientific journal, The Lancet, as part of their latest series, which is on tuberculosis.